Predicting Breast Cancer Treatment Response using Diffuse Optical Tomography and Ultrasound
Quing ZhuSteve PoplackFoluso O. AdemuyiwaCatherine A. Young
Abstract
This clinical study validates an early treatment window for predicting complete or near-complete pathological response of breast cancer patients based on pretreatment total-hemoglobin level (THb), early changes of THb and ultrasound measurements following neoadjuvant chemotherapy.
Metrics
Topics
Related Documents
Predicting Treatment Response of Breast Cancer to Neoadjuvant Chemotherapy Using Ultrasound-Guided Diffuse Optical Tomography
Wenxiang ZhiGuangyu LiuCai ChangAiyu MiaoXiaoli ZhuLi XieJin Zhou
Predicting tumor response in breast cancer patients using diffuse optical tomography
Jacqueline GuntherEmerson A. LimHyun Keol KimMolly FlexmanSusan ReficeMindy A. BrownKevin KalinskyDawn L. HershmanAndreas H. Hielscher
Improved Breast Cancer Diagnosis using Ultrasound guided Diffuse Optical Tomography
K. M. Shihab UddinMenghao ZhangFrank J. BrooksMark A. AnastasioQuing Zhu
Early Assessment Window for Predicting Breast Cancer Neoadjuvant Therapy using Biomarkers, Ultrasound, and Diffuse Optical Tomography
Quing ZhuFoluso O. AdemuyiwaCatherine A. YoungCatherine M. AppletonMatthew F. CovingtonX. CynthiaSouzan SanatiIan S. HagemannAtahar MostafaK. M. Shihab UddinIsabella GrigsbyAshley FrithLeonel F. Hernandez‐AyaSteven Poplack
Optimal breast cancer diagnostic strategy using combined ultrasound and diffuse optical tomography
K. M. Shihab UddinMenghao ZhangMark A. AnastasioQuing Zhu